Stefano Azzariti
Investigation of in vitro susceptibility and resistance mechanisms in skin pathogens: perspectives for fluoroquinolone therapy in canine pyoderma
Azzariti, Stefano; Bond, Ross; Loeffler, Anette; Zendri, Flavia; Timofte, Dorina; Chang, Yu-Mei; Pelligand, Ludovic
Authors
Ross Bond
Anette Loeffler
Flavia Zendri
Dorina Timofte
Yu-Mei Chang
Ludovic Pelligand
Contributors
Joe Standing
Other
Abstract
Fluoroquinolones (FQ) are commonly used in dogs with bacterial skin infections. Their use as first choice, along with the increased incidence of FQ-resistance, represents a risk to animal and public health. Our study determined minimum inhibitory (MIC) and bactericidal (MBC) concentrations of five FQs in Staphylococcus aureus, Staphylococcus pseudintermedius and Escherichia coli, together with FQ-resistance mechanisms.
MICs, efflux pump (EP) overexpression and MBCs were measured in 249 skin infection isolates following CLSI guidelines (CLSI VET01-A4, CLSI M26-A). Chromosomal and plasmid mediated resistance genes were investigated after DNA extraction and sequencing. FQ-resistance was detected in 10% of methicillin-susceptible (MS), 90% of methicillin-resistant (MR) staphylococci and in 36% of E. coli. Bactericidal effect was observed except in 50% of MRSA/P for ciprofloxacin and in 20% of MRSPs for enrofloxacin. Highest MICs were associated with double mutation in gyrA (Ser83Leu+Asp87Asn), efflux pumps and three PMQR genes in E. coli, and grlA (Ser80Phe+Glu84Lys) in S. aureus. EP overexpression was high among E. coli (96%), low in S. aureus (1%) and absent in S. pseudintermedius.
Pradofloxacin and moxifloxacin showed low MICs with bactericidal effect. Since in vitro FQ resistance was associated with MR, FQ use should be prudently guided by susceptibility testing.
Citation
Azzariti, S., Bond, R., Loeffler, A., Zendri, F., Timofte, D., Chang, Y.-M., & Pelligand, L. (2022). Investigation of in vitro susceptibility and resistance mechanisms in skin pathogens: perspectives for fluoroquinolone therapy in canine pyoderma. Antibiotics, https://doi.org/10.3390/antibiotics11091204
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 3, 2022 |
Publication Date | Sep 6, 2022 |
Deposit Date | Sep 6, 2022 |
Publicly Available Date | Sep 6, 2022 |
Electronic ISSN | 2079-6382 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Issue | Antimicrobial Resistance and Treatment in Companion, Food and Exotic Animals |
DOI | https://doi.org/10.3390/antibiotics11091204 |
Publisher URL | https://www.mdpi.com/2079-6382/11/9/1204 |
Files
Investigation Of In Vitro Susceptibility And Resistance Mechanisms In Skin Pathogens Perspectives For Fluoroquinolone Therapy In Canine Pyoderma
(662 Kb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Version
VoR
You might also like
Time-Kill Analysis of Canine Skin Pathogens: A Comparisonof Pradofloxacin and Marbofloxacin
(2023)
Journal Article
Transverse sectioning in the evaluation of skin biopsy specimens from alopecic dogs.
(2020)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search